Overview

Cerebrolysin REGistry Study in Stroke

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Investigation of clinical practices, safety and effectiveness of Cerebrolysin in routine treatment of patients with acute ischemic stroke.
Details
Lead Sponsor:
Ever Neuro Pharma GmbH
Collaborator:
SITS International
Treatments:
Cerebrolysin